Alexion Pharma Nordics AB
556839-1022ActivePioneering transformative medicines for the global rare disease community.
Pharmaceutical Companyalexion.com
Yleiskatsaus
- 10–19
- Työntekijät
- 50–100milj SEK
- Liikevaihto
- 2011
- Perustettu
Avainpäättäjät
Marc Dunoyer
Chief Executive Officer
@alexion.com
Scott Weintraub
SVP, United States Business
@alexion.com
Shane Doyle
SVP, Head of Operations
@alexion.com
Soraya Bekkali
SVP, EUCAN and International Business
@alexion.com
+16 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Alexion, operating as AstraZeneca Rare Disease, is fundamentally dedicated to pioneering new possibilities for the global rare disease community. Their core mission revolves around transforming the lives of people affected by rare conditions through the development of transformative treatments and m...
ASTRAZENECA AS